Hear that? Smart stethoscope maker Eko Health just raised $41 million in new backing to help expand its commercial reach in ...

Lilly has vigorously defended the safety of donanemab and did so again in the lengthy FDA rebuttal. Specifically, the company ...

After taking 11 months to get to know Elsie Biotechnologies' oligonucleotide platform, GSK is ready to tie the knot with a ...

Biopharma investment trends continue to shift, with venture funding jumping to $7.4 billion across 188 deals for the first ...

Charles River Laboratories and Sanofi are working on a new project in which virtual control animals will take the place of ...

The IPO announcement comes two days after epilepsy biotech Rapport Therapeutics revealed plans for a $122 million IPO, one of ...

Digital business cards. Gilead’s virtual reality ride. Soccer’s Champions League final. A motorcycle brigade. | Digital ...

Gilead Sciences shared more data on its $4.3 billion, near-approval liver disease prospect Wednesday, linking the candidate ...

Vir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase 2 trial, suggesting the ...

Dexcom announced that its G7 diabetes sensor can now link directly to a user’s Apple Watch, allowing them to track their ...

It’s all systems go for Moon Surgical with a new FDA green light for its Maestro robotic laparoscopy platform. | It’s all ...

Lykos Therapeutics’ attempt to get the first ever MDMA treatment approved in post-traumatic stress disorder suffered a ...